Invention Grant
- Patent Title: Cycloalkane-1,3-diamine derivative
-
Application No.: US17243360Application Date: 2021-04-28
-
Publication No.: US11236106B2Publication Date: 2022-02-01
- Inventor: Kenji Yoshikawa , Noriyasu Haginoya , Tomoaki Hamada , Ryutaro Kanada , Jun Watanabe , Yoshiko Kagoshima , Eri Tokumaru , Kenji Murata , Takayuki Baba , Mayumi Kitagawa , Akiko Kurimoto , Masashi Numata , Machiko Shiroishi , Taeko Shinozaki
- Applicant: Daiichi Sankyo Company, Limited
- Applicant Address: JP Tokyo
- Assignee: Daiichi Sankyo Company, Limited
- Current Assignee: Daiichi Sankyo Company, Limited
- Current Assignee Address: JP Tokyo
- Agency: Christensen O'Connor Johnson Kindness PLLC
- Priority: JPJP2018-229397 20181206
- Main IPC: C07D495/04
- IPC: C07D495/04 ; A61P35/02 ; A61K45/06
Abstract:
The present invention provides a compound or a pharmaceutically acceptable salt thereof having an inhibitory action on the interaction between menin and an MLL protein. The compound represented by the formula (1) or a pharmaceutically acceptable salt thereof. wherein, in the formula (1), the dotted circle, R1, R2, R3, R4, R5, R6, R7, R8, Ring Q1, W, m and n are each as defined in the description.
Public/Granted literature
- US20210269454A1 CYCLOALKANE-1,3-DIAMINE DERIVATIVE Public/Granted day:2021-09-02
Information query
